These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7684094)

  • 1. [Amylase-producing plasma cell dyscrasia. Genomic analysis in a case of intramuscular tumor formation and a review of the literature].
    Hirota K; Waga K; Nagashima S; Waku S; Yamazaki T; Saito K; Furusawa S; Shishido H
    Rinsho Ketsueki; 1993 Feb; 34(2):177-82. PubMed ID: 7684094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquired amylase production induced by radiotherapy in a myeloma patient].
    Yamakawa T; Nagoshi H; Takahashi A; Fukumura R; Takahashi S; Nomura M; Isobe H; Ide K; Ayabe T; Shimizu S
    Rinsho Ketsueki; 1995 Oct; 36(10):1175-81. PubMed ID: 8531327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of amylase-producing cell lines: ectopic activation of the amylase gene by translocation.
    Hata H; Matsuzaki H; Sanada I; Takatsuki K
    Jpn J Clin Oncol; 1990 Sep; 20(3):246-51. PubMed ID: 1701504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ectopic production of amylase by a non-producing type of multiple myeloma].
    Wada H; Ohtsuki T; Sugihara T; Ata K; Hashimoto M; Yamada O; Yawata Y; Manabe T; Miyamoto K
    Rinsho Ketsueki; 1990 Jul; 31(7):1022-7. PubMed ID: 1699005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amylase-producing multiple myeloma: a case report].
    Mori M; Maruoka H; Nagai Y; Fujita H; Togami K; Tabata S; Kurata M; Matsushita A; Nagai K; Tanaka K; Yamashiro A; Takahashi T
    Rinsho Ketsueki; 2007 Nov; 48(11):1484-8. PubMed ID: 18080506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
    Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
    Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylase-producing plasmacytoma cell lines, AD3 and FR4, with der(14)t(8;14) and dic(8)t(1;8) established from ascites.
    Tagawa S; Doi S; Taniwaki M; Abe T; Kanayama Y; Nojima J; Matsubara K; Kitani T
    Leukemia; 1990 Aug; 4(8):600-5. PubMed ID: 1697013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma associated with sialyl salivary-type amylase.
    Shigemura M; Moriyama T; Shibuya H; Obara M; Endo T; Hashino S; Yokouchi H; Asaka M; Shimizu C; Chiba H; Nishimura M
    Clin Chim Acta; 2007 Feb; 376(1-2):121-5. PubMed ID: 16979610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
    Verdelli D; Mattioli M; Fabris S; Nobili L; Intini D; Guerneri S; Todoerti K; Zanella A; Deliliers GL; Lombardi L; Neri A
    Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylase-producing multiple myeloma.
    Fujii H; Yashige H; Kanoh T; Urata Y
    Arch Pathol Lab Med; 1991 Sep; 115(9):952-6. PubMed ID: 1718241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of interleukin-6 messenger RNA as malignant progression index in monoclonal gammapathy of undetermined significance].
    Mancini R; Palange M; Dionisi MG; De Angelis V; Matteocci A; Strano L
    Recenti Prog Med; 1999 Oct; 90(10):522-6. PubMed ID: 10592737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor producing amylase].
    Moriyama T; Tozawa T; Matsuno K
    Rinsho Byori; 2002 Jun; 50(6):566-70. PubMed ID: 12166074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
    Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
    Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.
    Mazur G; Bogunia-Kubik K; Wróbel T; Karabon L; Polak M; Kuliczkowski K; Lange A
    Immunol Lett; 2005 Jan; 96(2):241-6. PubMed ID: 15585329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
    Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
    Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.